Kozak & Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572 Hold
35
﹤0.01% 399
2026
Q1
$485 Hold
35
﹤0.01% 412
2025
Q4
$444 Buy
35
+1
+3% +$11 ﹤0.01% 401
2025
Q3
$367 Buy
+34
New +$331 ﹤0.01% 424
2023
Q3
Sell
-46
Closed -$454 419
2023
Q2
$454 Sell
46
-1
-2% -$10 ﹤0.01% 343
2023
Q1
$448 Buy
47
+1
+2% +$11 ﹤0.01% 332
2022
Q4
$1K Hold
46
﹤0.01% 327
2022
Q3
$0 Hold
46
﹤0.01% 384
2022
Q2
$0 Sell
46
-42
-48% -$460 ﹤0.01% 398
2022
Q1
$1K Hold
88
﹤0.01% 371
2021
Q4
$1K Buy
88
+1
+1% +$13 ﹤0.01% 371
2021
Q3
$1K Buy
+87
New +$1.23K ﹤0.01% 320

Other funds holding VTRS

Kozak & Associates's VTRS Position: Q2 2026 in Review

Kozak & Associates held its Viatris (VTRS) position steady in Q2 2026 at 35 shares worth $572. The position accounts for ﹤0.01% of the portfolio, ranked #399.

Kozak & Associates first reported a position in VTRS in Q3 2021 and has held it in 12 quarters since. The position peaked at $1K in Q4 2022. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Kozak & Associates held 35 shares of Viatris worth $572 as of Q2 2026.
  • Kozak & Associates left its Viatris share count unchanged in Q2 2026.
  • Viatris made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #399 holding.
  • Kozak & Associates first reported a position in Viatris in Q3 2021 and has held it in 12 quarters since.
  • Kozak & Associates's Viatris position peaked at $1K in Q4 2022.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.